HEMOFIX ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 288 | Autoimmune acquired coagulation factor deficiency | 1 |
288. Autoimmune acquired coagulation factor deficiency
Clinical trials : 206 / Drugs : 231 - (DrugBank : 28) / Drug target genes : 10 - Drug target pathways : 21
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01651468 (ClinicalTrials.gov) | September 2016 | 25/7/2012 | The Effect of the Nutraceutical Hemofix on the Coagulation System | Phase 1 Study of the Nutraceutical Hemofix Safety and Effect on the Coagulation System | Von Willebrand Disease;Menorrhagia | Dietary Supplement: HEMOFIX | Hadassah Medical Organization | HEMOFIX;Yocheved Grossman;Idan Grossman | Withdrawn | 18 Years | 75 Years | All | 0 | Phase 1 | Israel |